INTRODUCTION
Ventriculoperitoneal shunts (VPSs) have been the mainstay of treating hydrocephalus since the 1950s and have become one of the most frequently performed neurosurgical procedures. [1, 2, 19, 24] However, shunt failure is not uncommon with reported complications rates reaching nearly 50%, and the majority occur within the 1 st year of VPS placement. [25, 30] An estimated 30,000 shunts are placed each year in the United States, suggesting that the number of shunt failures presenting to the emergency room (ER) every year is in the tens of thousands. [2, 19] Common causes of shunt failure include infection, catheter obstruction, abdominal pseudocysts, and bowel perforation. [19, 23] e diagnosis of shunt malfunction can be difficult even for experienced clinicians. Classical symptoms of shunt malfunction are nonspecific and include headache, lethargy, nausea, and vomiting. [27] When patients present to the ER with symptoms of shunt failure, workup of shunt failure typically begins with brain imaging (computed tomography [CT] scans and shunt X-rays). Unfortunately, shunt failures do not necessarily lead to imaging changes, and hydrocephalus itself does not always indicate shunt failure. [10, 17, 29] Novel techniques utilizing magnetic resonance imaging can be useful in detecting cerebrospinal fluid (CSF) flow, although this has not been widely validated. [12, 16] Imaging can be followed by more invasive procedures, which include shunt tap, lumbar puncture (LP), and radionucleotide scans. However, these procedures are uncomfortable to the patient, carry risk of complications, and can be time consuming.
Cutaneous thermal diffusion techniques are promising noninvasive and quick techniques to assess CSF flow in a shunt. e ShuntCheck (Neuro Diagnostic Devices, Inc., Trevose, Pennsylvania) device uses temperature gradients to detect and quantify shunt CSF flow. e previous studies have shown that the device reliably determines CSF flow, confirmed by flow detection in the OR, with good sensitivity and specificity. [14] We sought to evaluate and review the utility of using this thermal sensor to aid in the diagnosis of patients that presented to the ER with symptoms of shunt failure. Patients that presented with classical symptoms and/or clear imaging or testing indicative of shunt failure did not need to undergo a thermal sensor examination. e thermal sensor assessments were reserved for patients who had equivocal presentations of shunt failure. We retrospectively analyzed a series of consecutive patients who underwent workup with a thermal sensor in the ER and review whether the results affected clinical decisions.
METHODS
is was a retrospective review at a single medical center ER with the Institutional Review Board approval. Written informed consent was waived for this study given a retrospective analysis of de-identified data. We included consecutive patients with the question of VPS malfunction who were evaluated with the thermal sensor device. e time period of data collection included September 2015-April 2018.
ShuntCheck procedure
Patients are positioned either flat, at 45°, or 90°. e ShuntCheck program provides step-by-step guidance and instruction on the use of their system. e shunt tubing was palpated as it crosses the clavicle, and a thermal sensor device is placed directly over the shunt where the catheter crosses the clavicle in line with the direction of tubing. An ice pack was placed to cool the skin and underlying catheter "upstream" of the thermal detector per protocol. If CSF is flowing through the shunt, the cooled fluid will preferentially cool the region of skin above the shunt tubing and this differential will propagate "downstream" and be detected by the thermal detector. e program detects CSF flow measuring the difference in cooling of the skin above the shunt tubing relative to the flanking skin. If the device detects a characteristic downstream transcutaneous temperature dip, the computer reports: "Flow confirmed. " A quantitative value based on the temperature curve is also reported as the natural flow amplitude (NFA). If no temperature dip is detected, the unit reports: "Flow not confirmed. " A real-time temperature graph is produced [ Figure 1 ]. [21] 
RESULTS
Eight patients were reviewed, including four males and four females. e average age of reviewed patients was 35.1 (±16.5) years old. e leading presenting symptom was headache, occurring in six of the eight patients. Other symptoms included lethargy, nausea, vomiting, and change in mental status. VPS devices included Medtronic Strata, Medtronic Delta, and Sophysa Polaris. Table 1 summarizes thermal sensor findings and ER outcomes for each patient. e average NFA in assessments resulting in no flow was 0.10, while the average NFA for positive detected flow was 0.46. e ShuntCheck program produces a graph correlating with the change in temperature detected by the sensor.
Five (62.5%) of the patients were discharged home after thermal sensor showed good flow (patients 1, 4, 5, 6, and 7). ree (37.5%) patients required intervention. One patient shunt valve setting was adjusted (patient 2) based on imaging findings showing increased ventricle caliber. Two other patients were admitted for shunt revisions based on a diagnosis of shunt failure (patients 3 and 8). In both of these patients, the thermal sensor revealed inadequate shunt flow.
Example 1 (patient 3)
A 26-year-old female with a history of idiopathic intracranial hypertension and VPS (Medtronic Delta) presented with headaches and blurry vision. Her shunt was placed 1 month before presentation at an outside hospital. CT head imaging revealed slit ventricles. LP revealed an opening pressure of 33 cm H2O. Ophthalmologic examination showed evidence of bilateral papilledema. ermal sensor at 90° showed slow flow (NFA: 0.17). Given high suspicion of shunt failure, the patient was admitted for shunt revision. At the time of surgery, the proximal catheter was noted to have obstruction of flow and appeared adherent to the choroid. e proximal catheter was replaced along with a new Medtronic Strata valve. Follow-up appointment revealed the resolution of papilledema although headache persisted.
Example 2 (patient 6)
A 28-year-old male from Germany with a history of epilepsy and hydrocephalus since infancy secondary to traumatic brain injury, with the first VPS at 5 years of age and extensive subsequent revisions presented with headache, nausea, and vomiting. e patient had lived in Europe until 3 weeks before presentation. e most recent revision was 1 month before presentation. CT imaging showed normal ventricle caliber and shunt series did not show any discontinuity or kinking. ermal sensor revealed good flow at 45° (NFA: 0.26). It was concluded that the shunt was functioning. Nausea and vomiting had resolved without intervention. Headaches persisted although the patient was agreeable to outpatient neurology follow-up for further headache management. e patient was discharged with instruction to follow up with both neurology and his neurosurgeon for further management of shunt.
For the patients that were discharged home, we reviewed at least 3 months of follow-up data after initial presentation. e previously discussed patient 6 had no follow-up data as the patient returned to Germany to see his original neurosurgeon. Of the remaining four patients, none required intervention in the subsequent 3 months. Patient 1 presented to the clinic 1 month later and continued to have headaches suggestive of overdrainage, so the Medtronic Strata shunt was dialed from setting 1.0 to 1.5. However, on follow-up 2 months later, this was more uncomfortable to the patient and the shunt setting was returned to 1.0. Patient 4 was seen in the clinic 2 months after the initial visit and had the Strata valve dialed down from 2.0 to 1.5. e patient had reported some improvement at another visit 2 months later. Patient 5 was seen in the clinic 4 months after presentation and noted to be doing well. Patient 7 was seen 2 and 6 months after presentation and noted to be doing well at each visit.
DISCUSSION
We demonstrate that thermal sensor is a clinically useful tool in the initial management and assessment of patients presenting with possible VPS failure. It can be used as a screening tool to either rule out obstruction or prompt further advanced testing. Clinical symptoms suggestive of VPS failure include headache, vomiting, decreased mental status, and fever. e majority of the patients included in this review had reported headaches, and the remaining two presented with a decreased level of consciousness. ese symptoms are often vague and have a wide differential in etiology. Conversely, some patients with shunt failure present with none of these symptoms. ere are potentially severe consequences of missing shunt failure, and it is important for the ER provider and/or neurosurgeon to make a careful and timely evaluation.
e routine workup for shunt failure often involves neuroimaging. CT and shunt series X-ray are the most common type of imaging obtained in the initial work-up. Imaging findings alone, however, are not indicative of shunt failure. [17] In some indications for VPS, such as normal pressure hydrocephalus, postoperative placement will not always change ventricular volume. [18] Due to this variability in findings, the diagnosis of shunt failure depends on a comprehensive assessment of the patient's complaints, examination findings, imaging, and objective measurements of shunt function.
Tapping the shunt reservoir is one objective measurement that can provide opening pressures and direct CSF analysis. [26] However, it is an invasive procedure and has theoretical risks of causing bleeding, infection, or CSF leakage from the puncture site. [6, 11, 13, 22] In many practices, a diagnostic shunt tap is used sparingly to minimize these risks. Alternatively, an LP can also be used to access CSF and obtain pressure measurements. Pressure readings are more accurate and useful when there are signs of communicating hydrocephalus, as proximal obstruction can lead to artificially low estimates of intracranial pressure. [20] Neither of these techniques, however, are able to assess the degree of flow in the shunt catheter in its natural state.
e thermal sensor tool is useful in distinguishing whether there is flow within the shunt system and aid in the diagnosis of shunt failure. e method of assessing flow through temperature fluctuations has been around for several decades. [3, 5, 7, 28] Studies suggested that the method could distinguish between proximal and distal blockage and would work in both VPS and lumboperitoneal shunts. [4, 5, 9] However, the technology had not been further studied until more recently with the development of a packaged, portable, and easy to use the system named the ShuntCheck. [21] Madsen et al. showed that the ShuntCheck device had good sensitivity and specificity in detecting CSF flow in pediatric patients. [14] In a more recent study, Hameed et al. found that the ShuntCheck results were associated with shunt revisions in pediatric patients and could serve as a diagnostic aid. [8] A separate group found inconsistent results with the ShuntCheck and reported several technical problems, including use on obese patients and excessive movement. [15] Few groups have used the ShuntCheck device in the adult population, which may be more tolerable to undergo a thermal sensor examination.
All of the patients reviewed in our study portray scenarios, in which the patient is rapidly evaluated and a point-of-care method and proper disposition can be decided in a shorter amount of time. Figure 2 provides a sample flowchart for integrating the thermal sensor into the workup of shunt failure. When a patient first presents with symptoms of shunt failure, the first step should still be neuroimaging. e thermal sensor becomes most useful in cases where the information provided by other diagnostic tools is equivocal.
A positive flow detected by a thermal sensor not only can reassure the clinician but also the patient. However, a shunt flow evaluation by itself is not a predictor of the clinical diagnosis of shunt failure, as the previous studies have shown. [8, 14] Patient 7 had a negative result but clinically improved, and no intervention was needed. e clinician can use thermal sensor results in combination with the clinical examination and other diagnostic testings to make the best decision for the patient. is series of patients illustrates a variety of clinical pictures, in which a thermal sensor device provided some insight into shunt function, which provided additional clinical data to help with decision-making.
Limitations
is is a small retrospective review with only eight patients, limiting the generalizability of our findings. e low number of patients is due to the fact that only a subset of patients presenting with symptoms of shunt malfunction will undergo a thermal sensor evaluation. e thermal sensor results are most useful in patients that have inconclusive presentation and imaging findings, and a further diagnostic test can be helpful. e decision tree in Figure 2 is not exhaustive, and the thermal sensor itself can also produce equivocal results when very limited flow is detected. While not represented in our set of patients, there are instances where an equivocal thermal sensor result warrants further investigation through a shunt tap or nuclear medicine study. In the patients included in our study, there is a significant heterogeneity, each patient with different indications for VPS and varying presenting symptoms. Further, the use of the device will help elucidate more of its' utility and challenges. It is important to note that the ShuntCheck device has not been widely validated, and its results on their own are not diagnostic of shunt failure. [15] e results of such studies should be used in adjunct to routine workup of shunt failure.
CONCLUSION
It is important to determine whether shunt dysfunction is present and whether an intervention is necessary for patients who present to the ER with possible symptoms of shunt failure. A thermal sensor device is a useful, fast, portable, and non-invasive tool in the evaluation of shunt flow and can help clinicians determine whether it is safe to send a patient home or intervene appropriately.
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